Proxima
Reprograming protein-protein interactions to unlock new small-molecule therapies for cancer, autoimmune disorders, and other hard-to-treat diseases
First Investment: 2014
There are many companies developing AI tools that help radiologists with diagnosis. But Enlitic uses AI for a different purpose: overcoming interoperability and data management challenges. The company’s applications standardize image data to provide a de-identified but clinically relevant study and series description of each image, making radiologists’ workflows vastly more efficient. Hospitals using Enlitic’s applications can then make smarter use of AI-based diagnostic algorithms.
Explore Companies
Chai Discovery
Transforming biology from a science into engineering
Valar Labs
Using AI models trained on digital pathology images to help oncologists make smarter cancer treatment decisions
DVLP Medicines
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing